CVS HEALTH Corp Net Income Loss

• CVS HEALTH Corp showed a decrease of -61.7% in Net Income Loss from 2024 to 2025.
• This data is from CVS HEALTH Corp's annual report (Form 10-K), filed with the SEC on February 10, 2026.
• XBRL data for this metric is available from 2007 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2008: $774.80 million | Q3 2008: $736.00 million | Q1 2009: $739.00 million | Q2 2009: $887.00 million | Q3 2009: $1.02 billion | Q4 2009: $1.05 billion | Q1 2010: $771.00 million | Q2 2010: $821.00 million | Q3 2010: $809.00 million | Q4 2010: $1.03 billion | Q1 2011: $713.00 million | Q2 2011: $816.00 million | Q1 2015: $1.22 billion | Q2 2015: $1.27 billion | Q3 2015: $1.25 billion | Q4 2015: $1.50 billion | Q1 2016: $1.15 billion | Q2 2016: $924.00 million | Q3 2016: $1.54 billion | Q4 2016: $1.71 billion | Q1 2017: $952.00 million | Q2 2017: $1.10 billion | Q3 2017: $1.29 billion | Q4 2017: $3.29 billion | Q1 2018: $998.00 million | Q2 2018: -$2.56 billion | Q3 2018: $1.39 billion | Q4 2018: -$419.00 million | Q1 2019: $1.42 billion | Q2 2019: $1.94 billion | Q3 2019: $1.53 billion | Q4 2019: $1.75 billion | Q1 2020: $2.01 billion | Q2 2020: $2.98 billion | Q3 2020: $1.22 billion | Q1 2021: $2.22 billion | Q2 2021: $2.78 billion | Q3 2021: $1.60 billion | Q1 2022: $2.35 billion | Q2 2022: $3.03 billion | Q3 2022: -$3.41 billion | Q1 2023: $2.14 billion | Q2 2023: $1.90 billion | Q3 2023: $2.26 billion | Q1 2024: $1.11 billion | Q2 2024: $1.77 billion | Q3 2024: $87.00 million | Q1 2025: $1.78 billion | Q2 2025: $1.02 billion | Q3 2025: -$3.98 billion.
• Over the full 16 years of available data (2007 to 2025), CVS HEALTH Corp's Net Income Loss has declined by 33.0%.
• Historical annual values: Fiscal year 2025: $1.77 billion | Fiscal year 2024: $4.61 billion | Fiscal year 2023: $8.34 billion | Fiscal year 2022: $4.31 billion | Fiscal year 2021: $8.00 billion | Fiscal year 2020: $7.18 billion | Fiscal year 2019: $6.63 billion | Fiscal year 2018: -$594.00 million | Fiscal year 2017: $6.62 billion | Fiscal year 2016: $5.32 billion | Fiscal year 2015: $5.24 billion | Fiscal year 2014: $4.64 billion | Fiscal year 2010: $3.43 billion | Fiscal year 2009: $3.70 billion | Fiscal year 2008: $3.20 billion | Fiscal year 2007: $2.64 billion.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026